The  estimated annual incidence of<unk><unk><unk><unk>  with steatosis in the United States is approximately 9,255 per 100,000 individuals. The prevalence of<unk><unk><unk><unk>  in the United States is estimated to be 10,000 to 24,000 cases per 100,000 individuals annually.<unk><unk><unk><unk><unk>  may occur at any age, but is diagnosed most commonly in patients aged 50 to 60 years. Hepatic steatosis is more prevalent in the hispanics.
Non-alcoholic fatty liver disease epidemiology and demographics
Fatty liver epidemiology and demographics
Alcoholic hepatitis epidemiology and demographics
Autoimmune hepatitis epidemiology and demographics
Primary biliary cirrhosis epidemiology and demographics
Cirrhosis epidemiology and demographics
Drug induced liver injury epidemiology and demographics
Hyperlipoproteinemia epidemiology and demographics